Cargando…
A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems
Lipid nanoparticle (LNP)-formulated mRNA vaccines were rapidly developed and deployed in response to the SARS-CoV-2 pandemic. Due to the labile nature of mRNA, identifying impurities that could affect product stability and efficacy is crucial to the long-term use of nucleic-acid based medicines. Her...
Autores principales: | Packer, Meredith, Gyawali, Dipendra, Yerabolu, Ravikiran, Schariter, Joseph, White, Phil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608879/ https://www.ncbi.nlm.nih.gov/pubmed/34811367 http://dx.doi.org/10.1038/s41467-021-26926-0 |
Ejemplares similares
-
Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021) -
Ionizable lipid nanoparticles for in utero mRNA delivery
por: Riley, Rachel S., et al.
Publicado: (2021) -
Delivery of mRNA to platelets using lipid nanoparticles
por: Novakowski, S., et al.
Publicado: (2019) -
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
por: Yang, Lei, et al.
Publicado: (2022) -
Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
por: Żak, Magdalena M., et al.
Publicado: (2021)